Autor: |
Singh SM; Department of Medicine, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, Toronto, Ont., Rau NV, Cohen LB, Harris H |
Jazyk: |
angličtina |
Zdroj: |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2004 Oct 26; Vol. 171 (9), pp. 1063-4. |
DOI: |
10.1503/cmaj.1040563 |
Abstrakt: |
Infliximab is a chimeric anti-tumour necrosis factor-alpha antibody that is efficacious in treating Crohn's disease. However, its immunomodulatory properties increase susceptibility to opportunistic infections. We present a case of cutaneous Nocardia infection in a patient who was taking infliximab for Crohn's disease. The case illustrates the challenges in the diagnosis and management of this disease and serves as a reminder of the complications associated with the use of immunomodulatory agents. |
Databáze: |
MEDLINE |
Externí odkaz: |
|